United Kingdom - English - myHealthbox

rosemont pharmaceuticals ltd - desloratadine - oral solution - 0.5mg/ml - antihistamines – h1 antagonist - it is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: - allergic rhinitis - urticaria

Kenya - English - Pharmacy and Poisons Board

bekra pharma uk ltd 13, lavington road, london - desloratadine usp - syrup - each 5ml contains desloratadine usp 2.5mg - desloratadine

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram limited - syrup - see ingredients - each 5,0 ml syrup contains desloratadine 2,5 mg

Canada - English - Health Canada

bayer inc - desloratadine - syrup - 0.5mg - desloratadine 0.5mg - second generation antihistamines

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)] . the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratoge

Kenya - English - Pharmacy and Poisons Board

each 5ml of syrup contains 2 milligrams of the… - syrup - each 5ml of syrup contains 2 milligrams of the… - chlorphenamine

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - desloratadine - tablets - desloratadine 5 mg - desloratadine - desloratadine - desloratadine - trima tablets are indicated in adults and adolescents aged 12 yars and older for the relief of symptoms associated with: - allergic rhinitis, - urticaria

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - desloratadine - syrup - desloratadine 0.5 mg/ml - desloratadine - for the relief of symptoms associated with allergic rhinitis and/or chronic idiopathic urticaria in adults and children 1 year of age and above.

United States - English - NLM (National Library of Medicine)

avpak - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. - desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions ( 5.1) and adverse reactions ( 6.2)]. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions ( 5.1) and adverse reactions ( 6.2)]. pregnancy category c: there are no adequate and well-controlled studies in pregnant

United States - English - NLM (National Library of Medicine)

dr. reddy's laboratories limited - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 2.5 mg - desloratadine orally disintegrating tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older. desloratadine orally disintegrating tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 6 months of age and older. desloratadine orally disintegrating tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2) ] risk summary the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratogenic at the summed area under the concentration-time curve (auc)-based exposures of desloratadine and its metabo